| Janet L Linton, MD | |
|
1815 Hand Ave, Bay Minette, AL 36507 | |
| (251) 476-2481 | |
| (251) 943-7115 |
| Full Name | Janet L Linton |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 39 Years |
| Location | 1815 Hand Ave, Bay Minette, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013966142 | NPI | - | NPPES |
| 051529425 | Other | AL | BCBS OF AL |
| 169835 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 00013024 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Baldwin Infirmary | Bay minette, AL | Hospital |
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Entity Name | J L Linton & Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356739569 PECOS PAC ID: 8022334838 Enrollment ID: O20150312002464 |
News Archive
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals.
EKF Molecular Diagnostics has agreed a collaboration with specialist medtech company ANGLE plc, to investigate the combination of ANGLE's Parsortix circulating tumour cell (CTC) harvesting platform with EKF Molecular's PointMan™ DNA enrichment technology as a liquid biopsy. If successful, the resulting simple blood test could enable the investigation of unexpected ultra-low level mutations in a patient's cancer for personalised cancer care.
Closely held companies that drop insurance coverage of birth control for religious reasons have 60 days to inform their employees, the administration said Thursday. The rule follows the Supreme Court's decision allowing some companies to opt out of the federal health law's mandate.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Janet L Linton, MD P.o. Box 2385, Fairhope, AL 36533-2385 Ph: (251) 476-2481 | Janet L Linton, MD 1815 Hand Ave, Bay Minette, AL 36507 Ph: (251) 476-2481 |
News Archive
Specialized risk scores derived from testing that calculates the cumulative effect of an individual's entire DNA sequence, the genome, may reliably predict heart disease in people who have not yet had a heart attack, according to new research in Circulation: Genomic and Precision Medicine, an American Heart Association journal.
Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals.
EKF Molecular Diagnostics has agreed a collaboration with specialist medtech company ANGLE plc, to investigate the combination of ANGLE's Parsortix circulating tumour cell (CTC) harvesting platform with EKF Molecular's PointMan™ DNA enrichment technology as a liquid biopsy. If successful, the resulting simple blood test could enable the investigation of unexpected ultra-low level mutations in a patient's cancer for personalised cancer care.
Closely held companies that drop insurance coverage of birth control for religious reasons have 60 days to inform their employees, the administration said Thursday. The rule follows the Supreme Court's decision allowing some companies to opt out of the federal health law's mandate.
› Verified 5 days ago